Welcome to the international HTA database

Showing [23537 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2020	Malaysian Health Technology Assessment (MaHTAS)	Repetitive transcranial magnetic stimulation (rTMS) for patients with stroke
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ibrutinib (new therapeutic indication, chronic lymphocytic leukaemia) - Benefit assessment according to §35a Social Code Book V]
2020	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Proposal for the organization of bariatric medicine for the territories of the integrated university health and social services network of Laval University]
2020	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Exploratory evaluation of the relevance, use, and impacts of teleconsultations]
2020	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Field evaluation of the implementation of video teleconsultations during the COVID-19 pandemic at the Quebec Heart and Lung Institute]
2020	NIHR Health Services and Delivery Research programme	Enhancing the credibility, usefulness and relevance of patient experience data in services for people with long-term physical and mental health conditions using digital data capture and improved analysis of narrative data (DEPEND)
2020	NIHR Health Services and Delivery Research programme	The role of hospital organisation, surgical factors, and the enhanced recovery pathway, on patient outcomes and NHS costs following primary hip and knee replacement surgery: spatial and longitudinal analysis of routine data
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ropeginterferon alfa-2b (polycythaemia vera) - Benefit assessment according to §35a Social Code Book V]
2020	NIHR Health Services and Delivery Research programme	Implementation of an evidence based pelvic floor muscle training intervention for women with pelvic organ prolapse (PROlapse and PFMT: implementing Evidence Locally - PROPEL)
2020	Health Technology Wales (HTW)	Rapid collaborative review on the diagnostic accuracy of molecular methods that detect the presence of the SARS-COV-2 virus in people with suspected COVID-19
2020	NIHR Health Services and Delivery Research programme	ERA Electronic Records in Ambulances to support the shift to out of hospital care: challenges, opportunities and workforce implications
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: continuous glucose monitoring system (Dexcom G6, Dexcom)]
2020	NIHR Health Services and Delivery Research programme	Dementia undetected or undiagnosed in primary care: the prevalence, causes and consequences
2020	National Institute for Health and Care Excellence (NICE)	Swallowable gastric balloon capsule for weight loss. NICE interventional procedures guidance 684
2020	NIHR Health Technology Assessment programme	Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs
2020	National Institute for Health and Care Excellence (NICE)	Pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis. NICE interventional procedures guidance 681
2020	NIHR Health Technology Assessment programme	Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis
2020	National Institute for Health and Care Excellence (NICE)	Balloon cryoablation for Barrett's oesophagus. NICE interventional procedures guidance 682
2020	NIHR Health Technology Assessment programme	Open urethroplasty versus endoscopic urethrotomy for recurrent urethral stricture in men: the OPEN RCT
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: Takhzyro (lanadelumab), notice of inclusion on the Liste des produits du système du sang du Québec]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Atezolizumab (NSCLC, combination chemotherapy with nab-paclitaxel) - Benefit assessment according to §35a Social Code Book V]
2020	National Institute for Health and Care Excellence (NICE)	Balloon cryoablation for squamous dysplasia of the oesophagus. NICE interventional procedures guidance 683
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: tomosynthesis and breast cancer: diagnostic evaluation and other uses]
2020	Canary Health Service	[Cost-effectiveness of universal childhood vaccination against hepatitis A (update)]
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Personal protective equipment and evidence-based advice for surgical departments during COVID-19
2020	National Institute for Health and Care Excellence (NICE)	Transcranial magnetic stimulation for auditory hallucinations. NICE interventional procedures guidance 680
2020	NIHR Health Technology Assessment programme	An online randomised controlled trial to evaluate the clinical and cost effectiveness of a peer supported self-management intervention for relatives of people with psychosis or bipolar disorder: Relatives Education And Coping Toolkit (REACT)
2020	Swiss Federal Office of Public Health (FOPH)	Dual antiplatelet therapy following percutaneous coronary intervention
2020	Canary Health Service	[Liquid biopsy for the detection of ovarian or endometrial cancer in samples taken from the Pap smear: PapSEEK]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cannabidiol (Dravet syndrome) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Surgery triage during the COVID-19 pandemic
2020	National Institute for Health and Care Excellence (NICE)	Deep brain stimulation for refractory epilepsy in adults. NICE interventional procedures guidance 678
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: first-line treatment of oral candidiasis in adults]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cannabidiol (Lennox-Gastaut syndrome) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Screening and testing for COVID-19 before surgery
2020	National Institute for Health and Care Excellence (NICE)	Implanted vagus nerve stimulation for treatment-resistant depression. NICE interventional procedures guidance 679
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: pharmacological treatment for fecal elimination in a person receiving palliative care or presenting a geriatric profile]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Development of scientific concepts for the generation of routine practice data and their analysis for the benefit assessment of drugs according to §35a Social Code Book V - rapid report]
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Safe surgery during the coronavirus disease 2019 crisis
2020	National Institute for Health and Care Excellence (NICE)	Transcranial magnetic stimulation for obsessive-compulsive disorder. NICE interventional procedures guidance 676
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: initiating a blood profile after detecting suggestive symptoms and signs of mild or major neurocognitive disorder]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Trifluridine/tipiracil (gastric cancer) - Benefit assessment according to §35a Social Code Book V]
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Surgery triage: responding to the COVID-19 pandemic. A rapid review comissioned by RACS
2020	National Institute for Health and Care Excellence (NICE)	Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease. NICE interventional procedures guidance 677
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Asfotase alfa (hypophosphatasia) - Benefit assessment according to §35a Social Code Book V]
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Guidelines for safe surgery: open versus laparoscopic. A rapid review commissioned by RACS
2020	National Institute for Health and Care Excellence (NICE)	Artificial iris insertion for acquired aniridia. NICE interventional procedures guidance 674
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use of immunoglobulins in hematology]
2020	Swiss Federal Office of Public Health (FOPH)	Vitamin D testing
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Larotrectinib (solid tumours) - Benefit assessment according to §35a Social Code Book V]
2020	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Guidelines for personal protective equipment. A rapid review comissioned by RACS
2020	National Institute for Health and Care Excellence (NICE)	Artificial iris insertion for congenital aniridia. NICE interventional procedures guidance 675
2020	NIHR Health Technology Assessment programme	Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use of immunoglobulins in clinical immunology]
2020	Canary Health Service	[Transcranial magnetic stimulation for the treatment of cocaine addiction]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Niraparib (ovarian cancer) - Benefit assessment according to §35a Social Code Book V]
2020	National Institute for Health and Care Excellence (NICE)	Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention. NICE interventional procedures guidance 673
2020	NIHR Health Services and Delivery Research programme	Optimising acute care for people with dementia: a mixed-methods study
2020	Institute for Clinical and Economic Review (ICER)	Supervised injection facilities and other supervised consumption sites: effectiveness and value
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Relationship between volumes of services and quality of treatment outcome in the surgical treatment of breast cancer - rapid report]
2020	National Institute for Health and Care Excellence (NICE)	Bilateral cervicosacropexy (CESA) or vaginosacropexy (VASA) using mesh for pelvic organ prolapse. NICE interventional procedures guidance 669
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: use of sedation and general anesthesia in pediatric dental care]
2020	Canary Health Service	[Physical exercise intervention in older hospitalized patients for the prevention of functional and cognitive deterioration during hospital admission]
2020	Institute for Clinical and Economic Review (ICER)	Nadofaragene firadenovec and oportuzumab monatox for BCG-unresponsive, non-muscle invasive bladder cancer: effectiveness and value
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ravulizumab (paroxysmal nocturnal haemoglobinuria) - Addendum to Commission A19-59]
2020	National Institute for Health and Care Excellence (NICE)	Cyanoacrylate glue occlusion for varicose veins. NICE interventional procedures guidance 670
2020	NIHR Health Technology Assessment programme	Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT
2020	NIHR Health Services and Delivery Research programme	Dementia and cognitive impairment in the older prison population of England and Wales: identifying individual need and developing a skilled, multi-agency workforce to deliver targeted and responsive services
2020	Canary Health Service	[Safety, clinical effectiveness and cost-effectiveness of interventions for the prevention of delirium in hospital admissions]
2020	Institute for Clinical and Economic Review (ICER)	Digital health technologies as an adjunct to medication assisted therapy for opioid use disorder
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Dolutegravir/lamivudine (HIV infection) - Addendum to Commission A19-55]
2020	National Institute for Health and Care Excellence (NICE)	MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy. NICE interventional procedures guidance 671
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: the therapeutic value of hyperbaric oxygen (HBO) on children with cerebral palsy]
2020	Canary Health Service	[Effectiveness, safety and cost-effectiveness of real-time continuous interstitial glucose monitoring systems (CGMS-RT) for Diabetes Mellitus type 1 and 2. Update]
2020	Institute for Clinical and Economic Review (ICER)	Valoctocogene roxaparvovec and emicizumab for hemophilia A without inhibitors: effectiveness and value
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Dolutegravir/lamivudine (HIV infection) - Second Addendum to Commission A19-55]
2020	National Institute for Health and Care Excellence (NICE)	Selective internal radiation therapy for unresectable colorectal metastases in the liver. NICE interventional procedures guidance 672
2020	NIHR Health Technology Assessment programme	Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT
2020	Austrian Institute for Health Technology Assessment (AIHTA)	Genetic testing in the context of familial hypercholesterolaemia management. Organisational and ethical implications (part 1), and economic aspects (part 2)
2020	Canary Health Service	[Safety, effectiveness, and cost-effectiveness of integrated continuous subcutaneous insulin infusion systems with continuous glucose monitoring sensor]
2020	Institute for Clinical and Economic Review (ICER)	Targeted immune modulators for ulcerative colitis: effectiveness and value
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ramucirumab (hepatocellular carcinoma) - Addendum to Commission A19-73]
2020	National Institute for Health and Care Excellence (NICE)	Fetoscopic prenatal repair for open neural tube defects in the fetus. NICE interventional procedures guidance 667
2020	Austrian Institute for Health Technology Assessment (AIHTA)	[Lung cancer screening in risk groups]
2020	Canary Health Service	[Cost-effectiveness analysis of newborn screening for severe combined immunodeficiency]
2020	Institute for Clinical and Economic Review (ICER)	Modulator treatments for cystic fibrosis: effectiveness and value
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Dupilumab (atopic dermatitis in adolescents) - Addendum to Commission A19-75]
2020	National Institute for Health and Care Excellence (NICE)	Open prenatal repair for open neural tube defects in the fetus. NICE interventional procedures guidance 668
2020	NIHR Health Technology Assessment programme	High-dose oral vitamin D supplementation and mortality in people aged 65 84 years: the VIDAL cluster feasibility RCT of open versus double-blind individual randomisation
2020	NIHR Health Services and Delivery Research programme	Access to primary and community health-care services for people 16 years and over with intellectual disabilities: a mapping and targeted systematic review
2020	Basque Office for Health Technology Assessment (OSTEBA)	[Efficacy and safety of mechanical thrombectomy in the treatment of patients with ischaemic stroke beyond 6 hours after onset or with an unknown time of onset]
2020	Austrian Institute for Health Technology Assessment (AIHTA)	Lung cancer screening in risk groups: a review-update of the economic evidence (Part II)
2020	Institute for Clinical and Economic Review (ICER)	Alternative pricing models for remdesivir and other potential treatments for COVID-19
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ivacaftor (combination with ivacaftor/tezacaftor, cystic fibrosis, 12 years and older, with F508del mutation, homozygous) - Addendum to Commission A19-70]
2020	Health Information and Quality Authority (HIQA)	Evidence summary for natural history of COVID-19 in children
2020	National Institute for Health and Care Excellence (NICE)	Reducing the risk of transmission of Creutzfeldt–Jakob disease (CJD) from surgical instruments used for interventional procedures on high-risk tissues. NICE interventional procedures guidance 666
2020	Basque Office for Health Technology Assessment (OSTEBA)	[Neonatal hearing screening programmes: A systematic review of economic evaluation studies and descriptive analysis of Spanish regional programmes]
2020	Ontario Health	Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis at Low Surgical Risk
2020	Canary Health Service	[Radiofrequency ablation for metastatic spinal lesions]
2020	Institute for Clinical and Economic Review (ICER)	Acute treatments for migraine